1. Home
  2. NEPH vs TOI Comparison

NEPH vs TOI Comparison

Compare NEPH & TOI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NEPH
  • TOI
  • Stock Information
  • Founded
  • NEPH 1997
  • TOI 2007
  • Country
  • NEPH United States
  • TOI United States
  • Employees
  • NEPH N/A
  • TOI N/A
  • Industry
  • NEPH Medical/Dental Instruments
  • TOI Medical/Nursing Services
  • Sector
  • NEPH Health Care
  • TOI Health Care
  • Exchange
  • NEPH Nasdaq
  • TOI Nasdaq
  • Market Cap
  • NEPH 15.9M
  • TOI 15.5M
  • IPO Year
  • NEPH 2004
  • TOI N/A
  • Fundamental
  • Price
  • NEPH $1.54
  • TOI $0.21
  • Analyst Decision
  • NEPH Buy
  • TOI Strong Buy
  • Analyst Count
  • NEPH 1
  • TOI 1
  • Target Price
  • NEPH $5.00
  • TOI $2.50
  • AVG Volume (30 Days)
  • NEPH 9.8K
  • TOI 3.0M
  • Earning Date
  • NEPH 11-07-2024
  • TOI 11-13-2024
  • Dividend Yield
  • NEPH N/A
  • TOI N/A
  • EPS Growth
  • NEPH N/A
  • TOI N/A
  • EPS
  • NEPH N/A
  • TOI N/A
  • Revenue
  • NEPH $13,546,000.00
  • TOI $378,933,000.00
  • Revenue This Year
  • NEPH N/A
  • TOI $29.17
  • Revenue Next Year
  • NEPH $9.13
  • TOI $16.43
  • P/E Ratio
  • NEPH N/A
  • TOI N/A
  • Revenue Growth
  • NEPH 0.03
  • TOI 22.29
  • 52 Week Low
  • NEPH $1.36
  • TOI $0.13
  • 52 Week High
  • NEPH $4.04
  • TOI $2.50
  • Technical
  • Relative Strength Index (RSI)
  • NEPH 47.64
  • TOI 49.25
  • Support Level
  • NEPH $1.53
  • TOI $0.17
  • Resistance Level
  • NEPH $1.64
  • TOI $0.24
  • Average True Range (ATR)
  • NEPH 0.06
  • TOI 0.04
  • MACD
  • NEPH -0.01
  • TOI 0.00
  • Stochastic Oscillator
  • NEPH 37.50
  • TOI 29.47

About NEPH Nephros Inc.

Nephros Inc is a commercial-stage company that develops and sells high-performance water solutions to the medical and commercial markets. In medical markets, it sells water filtration products and waterborne pathogen detection products. In commercial markets, the company manufactures and sells water filters that improve the taste and odor of water and reduce biofilm, bacteria, and scale build-up in downstream equipment. The company's subsidiary is engaged in the development of its second-generation hemodiafiltration system and other products focused on improving therapies for patients with renal disease.

About TOI The Oncology Institute Inc.

The Oncology Institute Inc offers oncology services committed to improving cancer prevention, diagnosis, treatment, research, and education. The company provides services including infusion centres. In-house dispensary, Outpatient blood transfusion, Outpatient stem cell transplant, financial counseling, clinical trials, comprehensive lab testing, and end-of-life counseling. The business operates in three operating segments dispensary, patients services and clinical trials and others. Key revenue is earned from providing patient services.

Share on Social Networks: